MSF Urges Pfizer, GlaxoSmithKline To Cut Pneumococcal Vaccine Prices For Children In Developing Countries

The Guardian: Pharmaceutical companies told to slash price of pneumococcal disease vaccine
“Two giant pharmaceutical companies should lower the price of a new vaccine against pneumococcal disease that is needed by children in developing countries, but is unaffordable for some of their governments, say the volunteer doctors of Médecins Sans Frontières (MSF)…” (Boseley, 1/20).

Reuters: MSF slams expensive vaccines, urges GSK and Pfizer to cut prices
“…In a report on vaccine prices ahead of an international donor conference in Berlin at the end of January, MSF slammed Big Pharma companies and said the cost of vaccinating a child in the world’s poorest countries was now 68 times higher than in 2001…” (Kelland, 1/20).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.